Rodent models of glaucoma and their applicability for drug discovery
- PMID: 28075618
- DOI: 10.1080/17460441.2017.1281244
Rodent models of glaucoma and their applicability for drug discovery
Abstract
Rodents have widely been used to represent glaucomatous changes both in the presence and absence of elevated intraocular pressure (IOP) as they offer clear advantages over other animal species. IOP elevation is commonly achieved by creating an obstruction in the aqueous outflow pathways, consequently leading to retinal ganglion cell and optic nerve (ON) damage, the hallmark of glaucoma. These changes may also be achieved in the absence of elevated IOP by directly inflicting injury to retina or ON. Areas covered: This paper presents a summary of currently used rodent models of glaucoma. The characteristics of these models from several studies are summarized. The benefits and shortcomings of these models are also discussed. Expert opinion: The choice of animal model that closely represents human disease is key for successful translational of preclinical research to clinical practice. Rodent models of rapid IOP elevation are likely to be least representative, whereas models such as steroid-induced glaucoma models more closely resemble the trabecular meshwork changes seen in glaucomatous human eyes. However, this model needs further characterization. Rodent models based on direct retinal and ON injury are also useful tools to investigate molecular mechanisms involved at the site of final common pathology and neuroprotective strategies.
Keywords: Glaucoma models; intraocular pressure; optic nerve; retinal ganglion cells; rodents.
Similar articles
-
Review of rodent hypertensive glaucoma models.Acta Ophthalmol. 2019 May;97(3):e331-e340. doi: 10.1111/aos.13983. Epub 2018 Dec 13. Acta Ophthalmol. 2019. PMID: 30549197 Review.
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
Exploring the current use of animal models in glaucoma drug discovery: where are we in 2023?Expert Opin Drug Discov. 2023 Jul-Dec;18(11):1287-1300. doi: 10.1080/17460441.2023.2246892. Epub 2023 Aug 22. Expert Opin Drug Discov. 2023. PMID: 37608634 Review.
-
[The dawn of neuroprotective therapy for glaucomatous optic neuropathy].Nippon Ganka Gakkai Zasshi. 2001 Dec;105(12):866-83. Nippon Ganka Gakkai Zasshi. 2001. PMID: 11802458 Review. Japanese.
-
Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.Invest Ophthalmol Vis Sci. 2002 Feb;43(2):402-10. Invest Ophthalmol Vis Sci. 2002. PMID: 11818384
Cited by
-
Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres.Drug Deliv. 2021 Dec;28(1):2427-2446. doi: 10.1080/10717544.2021.1998245. Drug Deliv. 2021. PMID: 34763590 Free PMC article.
-
Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress.Mol Vis. 2018 Jul 25;24:495-508. eCollection 2018. Mol Vis. 2018. PMID: 30090013 Free PMC article.
-
A Robust Microbead Occlusion Model of Glaucoma for the Common Marmoset.Transl Vis Sci Technol. 2022 Jan 3;11(1):14. doi: 10.1167/tvst.11.1.14. Transl Vis Sci Technol. 2022. PMID: 35019964 Free PMC article.
-
Taurine: A Source and Application for the Relief of Visual Fatigue.Nutrients. 2023 Apr 12;15(8):1843. doi: 10.3390/nu15081843. Nutrients. 2023. PMID: 37111062 Free PMC article.
-
Taurine protects against retinal and optic nerve damage induced by endothelin-1 in rats via antioxidant effects.Neural Regen Res. 2018 Nov;13(11):2014-2021. doi: 10.4103/1673-5374.239450. Neural Regen Res. 2018. PMID: 30233077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous